Subject: MJNA Commends Senate Move to Stay Out of State Medical Cannabis Laws

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA Commends Senate Move to Stay Out of State Medical Cannabis Laws
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)


Price: 0.1084

Change (%): + 0.0008 (0.79)

Volume: 2,045,606
MJNA Chart

Medical Marijuana, Inc. Commends Senate Appropriations Committee Renewal of the Rohrabacher-Farr Amendment

SAN DIEGO, July 31, 2017 /PRNewswire/ - Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it supports the decision of the Senate Appropriations Committee to approve renewal of the Rohrabacher-Farr amendment, which prohibits the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws. The amendment was enacted in 2014 and has been renewed each year since then.

As America took its latest step in protecting its state-sanctioned medical cannabis programs, just south of the border a group of renowned doctors met to discuss the therapeutic benefits of cannabis. During the LX Annual Meeting and National Congress of the Mexican Chapter of the International League Against Epilepsy in Tijuana, Mexico, Medical Marijuana Inc. subsidiary HempMeds® Mexico provided information about cannabinoid products for the treatment of neurodegenerative conditions, such as epilepsy. The event shared results obtained by Mexican doctors using the first cannabis based treatment approved in Mexico that is the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™).

“We are encouraged by the United States Senate Appropriations Committee’s decision to protect the wellbeing of millions of patients in states that have taken the necessary steps to create a legal cannabis program by renewing this amendment,” said Medical Marijuana Inc. CEO Dr. Stuart Titus. “With 60% of US States now with medical cannabis laws in place, it would be absurd not to ensure the success of these fully state-sanctioned cannabis programs.”

In the United States, a total of 30 states, the District of Columbia, Guam and Puerto Rico now allow for comprehensive public medical cannabis programs. Sixteen states allow the use of low THC, high cannabidiol (CBD).

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks